[Improving prognosis with docetaxel and monoclonal antibodies].
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D004317:Doxorubicin / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008081:Liposomes; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy / Q000451:nursing*; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000451:nursing*; D017410:Practice Guidelines as Topic; D011379:Prognosis; D016032:Randomized Controlled Trials as Topic
D000903:Antibiotics, Antineoplastic; D008081:Liposomes; D004317:Doxorubicin